Biobanking market was valued at $8.3 billion in 2024 and is projected to reach $20.1 billion by 2035, growing at a CAGR of 8.4% during the forecast period (2025–2035). The global biobanking market growth is driven by increasing demand for biological sample storage and management to support clinical research, precision medicine, and drug discovery activities worldwide. The adoption of biobanking solutions is influenced by technological advancements in automated sample handling systems, digital management platforms, and laboratory information management systems (LIMS), as well as the expanding role of biobanks in genomics, personalized medicine, and multi-omics research. Regulatory frameworks and ethical standards in major markets support standardized biobank operations, including protocols for sample collection, storage, and data governance, which contribute to wider market adoption.

Bioabsorbable stents market was valued at $150.3 million in 2025 and is projected to reach $242.9 million by 2035, growing at a CAGR of 5.0% during the forecast period (2026-2035). The rising adoption of bioabsorbable stents in cardiovascular and vascular treatments is transforming interventional procedures by offering temporary vessel support without leaving permanent implants. These stents gradually dissolve within the body after restoring blood flow, reducing long-term complications associated with traditional metallic stents. Bioabsorbable stents are widely used in coronary artery disease, peripheral artery disease, and pediatric cardiology, supporting safer and more natural vessel healing.

Asia-Pacific Breathalyzer market size reached $860.6 million in 2024 and is projected to expand to $5,194.8 million by 2035, growing at a CAGR of 17.8% during the forecast period (2025–2035). Market growth is supported by rising road safety regulations, stricter drunk-driving enforcement, and increased workplace alcohol testing requirements.

Asia-Pacific air conditioning market size reached $64.9 billion in 2025 and is projected to expand to $96.2 billion by 2035, growing at a CAGR of 4.1% during the forecast period (2026–2035). Market growth is supported by urbanization, construction activity, and rising cooling demand across residential and commercial buildings.

Animal vaccine market was valued at $13.5 billion in 2024 and is projected to reach $38.7 billion by 2035, growing at a CAGR of 10.1% during the forecast period (2025-2035). The growth of the global animal vaccine market is driven by increasing demand for livestock and poultry products across developed and emerging economies. Higher consumption of meat, dairy, eggs, and aquaculture products has led producers to place greater emphasis on animal health management to maintain production levels and reduce disease-related losses. Vaccination is used as a preventive measure to control disease outbreaks, improve herd health, and support the continuity of food supply chains. As commercial farming systems expand, routine immunization practices are being adopted across cattle, poultry, swine, and aquaculture segments.

The global air conditioning market size reached $124.9 billion in 2025 and is projected to expand to $175.5 billion by 2035, growing at a CAGR of 3.5% during the forecast period (2026–2035). Market growth is supported by urbanization, rising building construction, and efficiency-focused cooling regulations.

RF-over-Fiber (RFoF) market was valued at $460.5 million in 2025 and is projected to reach $900.4 million by 2035, growing at a CAGR of 7.0% during the forecast period (2026–2035). RFoF is increasingly being adopted in defense and aerospace sectors as it transmits high-frequency signals over long distances with low loss and strong immunity to electromagnetic interference. This capability makes RFoF particularly suitable for radar systems, satellite communications, electronic warfare, and unmanned aerial platforms, where maintaining signal integrity and minimizing latency is critical. The technology also supports wide bandwidths and flexible deployment, enabling secure and reliable communication in both fixed and mobile applications, including harsh operational environments.

Polypropylene market was valued at $106.5 billion in 2025 and is projected to reach $171.2 billion by 2035, growing at a CAGR of 4.9% during the forecast period (2026–2035). Artificial intelligence and digitalization are becoming increasingly relevant in the global polypropylene market as producers confront tightening margins, volatile feedstock costs, and growing competitive pressure from new capacity additions. Propylene prices’ close link to crude oil and natural-gas fluctuations creates persistent cost uncertainty for manufacturers, and oversupply in Asia along with logistical disruptions further pressures profitability. AI-driven optimization offers a structured response by converting real-time market, sensor, and historical plant data into operational adjustments that reduce raw-material consumption, energy use, and transition losses. These technologies support more accurate forecasting of propylene needs, stabilize reactor performance, and minimize off-spec volumes during specialty-grade changes. 

Anti-jamming system market was valued at $6.8 billion in 2025 and is projected to reach $15.9 billion by 2035, growing at a CAGR of 8.9% during the forecast period (2026–2035). The global anti-jamming system market is experiencing rapid growth as governments, aviation authorities, and industry stakeholders prioritize the protection of critical navigation systems against rising threats such as GNSS jamming and spoofing. The increasing reliance on satellite-based navigation in aviation, transportation, and defence has intensified the demand for advanced solutions that integrate adaptive digital processing, multi-antenna technologies, and machine learning to provide secure and uninterrupted positioning, navigation, and timing (PNT). For instance, in June 2025, European Space Agency (ESA) and Leonardo have initiated a joint NAVISP project to develop Machine Learning-powered smart antennas designed to block jamming and unwanted satellite signals, enhancing GNSS resilience.

European diabetes care drugs market was valued at $29.3 billion in 2025 and is projected to reach $56.7 billion by 2035, growing at a CAGR of 6.9% during the forecast period (2026–2035). The Europe diabetes drug market is witnessing sustained expansion, primarily driven by the increasing prevalence of diabetes across the region. According to the International Diabetes Federation, diabetes prevalence in Europe is estimated at 9.8%, representing approximately 66 million diagnosed cases. This figure is projected to rise by nearly 10% by 2050, indicating a growing disease burden. Europe accounts for the highest number of type 1 diabetes cases, estimated at 2.7 million. From this total, nearly 15% are reported among individuals below 20 years of age, amounting to around 419,000 cases. The rising incidence of both type 1 and type 2 diabetes continues to accelerate demand for effective drug therapies. In 2024, diabetes-related healthcare expenditure in the region was estimated at USD 193 billion. This expenditure represented nearly 19% of total global diabetes spending. Additionally, Europe ranks second in terms of average cost per diabetes case, estimated at USD 2,951. These factors collectively highlight the strong growth potential of the diabetes drug market in Europe.